Skip to main content
OpenTrials

Clinical trial condition

Basal Ganglia Diseases

Explore clinical trials studying Basal Ganglia Diseases. Study availability and eligibility vary by location and protocol.

4,056 public trials 750 recruiting studies
Refine in advanced search Browse all conditions

Basal Ganglia Diseases trial results

Completed

A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease

NCT01176240

Conditions
Asthenia, Autonomic Nervous System Diseases, Basal Ganglia Diseases, +24 more
Locations
  • Neurology Neurodiagnostic Lab Alabaster, Alabama, United States
  • Neurological Physicians of Arizona Gilbert, Arizona, United States
  • Xenoscience Phoenix, Arizona, United States
  • Barrow Neurology Clinic Phoenix, Arizona, United States
View all 60 locations
View Trial Details
Completed

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

NCT00633880

Conditions
Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +18 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Dedicated Clinical Research Litchfield Park, Arizona, United States
  • Xenoscience Inc. Phoenix, Arizona, United States
  • Sun Health Research Institute Sun City, Arizona, United States
View all 54 locations
View Trial Details
Completed

Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment

NCT00651183

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Boehringer Ingelheim Investigational Site Amstetten, Austria
  • Boehringer Ingelheim Investigational Site Bad Hall, Austria
  • Boehringer Ingelheim Investigational Site Bad Ischl, Austria
  • Boehringer Ingelheim Investigational Site Bad Radkersburg, Austria
View all 57 locations
View Trial Details
Completed

Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD

NCT00577460

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • 248.634.43005 Boehringer Ingelheim Investigational Site Linz, Austria
  • 248.634.42003 Boehringer Ingelheim Investigational Site Pardubice, Czechia
  • 248.634.42001 Boehringer Ingelheim Investigational Site Prague, Czechia
  • 248.634.42005 Boehringer Ingelheim Investigational Site Rakovník, Czechia
View all 70 locations
View Trial Details
Completed

a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients

NCT01361009

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Boehringer Ingelheim Investigational Site 54 Beijing, China
  • Boehringer Ingelheim Investigational Site 55 Beijing, China
  • Boehringer Ingelheim Investigational Site 56 Beijing, China
  • Boehringer Ingelheim Investigational Site 57 Beijing, China
View all 103 locations
View Trial Details
Completed

Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria

NCT00558467

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • 248.644.0026 Boehringer Ingelheim Investigational Site Bradenton, Florida, United States
  • 248.644.0025 Boehringer Ingelheim Investigational Site Tampa, Florida, United States
  • 248.644.0006 Boehringer Ingelheim Investigational Site Columbus, Georgia, United States
  • 248.644.0012 Boehringer Ingelheim Investigational Site Chicago, Illinois, United States
View all 16 locations
View Trial Details
Completed

A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa

NCT00782340

Conditions
Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +18 more
Locations
  • North Alabama Neuroscience Huntsville, Alabama, United States
  • Mayo Clinic-Arizona Scottsdale, Arizona, United States
  • Arkansas Cardiology Little Rock, Arkansas, United States
  • University of California, Irvine Irvine, California, United States
View all 21 locations
View Trial Details
Completed

Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease

NCT00558025

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • 248.636.3303A Boehringer Ingelheim Investigational Site Aix-en-Provence, France
  • 248.636.3303B Boehringer Ingelheim Investigational Site Aix-en-Provence, France
  • 248.636.3303C Boehringer Ingelheim Investigational Site Aix-en-Provence, France
  • 248.636.3307C Boehringer Ingelheim Investigational Site Bron, France
View all 36 locations
View Trial Details
Completed

Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)

NCT00321854

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • 248.595.0122 Boehringer Ingelheim Investigational Site Brimingham, Alabama, United States
  • 248.595.0104 Boehringer Ingelheim Investigational Site Scottsdale, Arizona, United States
  • 248.595.0133 Boehringer Ingelheim Investigational Site La Jolla, California, United States
  • 248.595.0140 Boehringer Ingelheim Investigational Site La Jolla, California, United States
View all 99 locations
View Trial Details

Related conditions